Bence György, Head of IOB’s Ophthalmic Translational Research Group, was elected as a member to the Gene Therapy Working Group of the Swiss Expert Committee for Biosafety (SECB).
The group supports the SECB in its advisory tasks related to the approval of clinical trials of gene therapy or genetically modified organisms (GMOs) and the market authorization of such products.
Find out more about the working group here.